DOCTOR ENGELBRECT ON LEAVE
Please be informed that Dr Engelbrecht will be on leave from Monday 27th November 2023 and will return Wednesday 3rd January 2024.
DOCTOR HAZELHURST ON LEAVE
Please be informed that Dr Hazelhurst will be on leave from Monday 18th December 2023 and will return on Wednesday 3rd January 2024.
DOCTOR CANTILLON ON LEAVE
Please be advised that Dr Cantillon will be on leave from Wednesday 3rd January 2024 and will return on Monday 15th January 2024
To ensure that your prescription requirements are met, please order your medication/s in advance through reception or "The Doctors App"
For continuity of care through this period, please contact reception to book an appointment with one of our other GPs. Alternatively Practice Plus, our primary after-hours service will be available for phone consultations.
CHRISTMAS - NEW YEAR PERIOD 2023/24
Please be advised that we will be closed from Saturday 23rd December 2023 and will resume normal hours Wednesday 3rd January 2024. In an emergency call 111.
For alternative consultations please contact Practice Plus
LATE PAYMENT FEE: Please be informed that as of 11th August 2023 we will be applying a late payment fee of $10.00 to ALL consultations not paid on the day. The late payment fee will be removed if payment is received within five days of the invoice date. If you are unable to pay your account on the day please, speak with one of our friendly receptionists, we are happy to discuss alternative ways of managing your account.
ADMINISTRATION FEE: As of the 30th August we will be applying a $10.00 administration fee for outstanding invoices not paid by the end of the month
TEST RESULTS: We DO NOT contact patients with test results unless they are abnormal results. If you would like to further discuss your results or, have any questions, please phone the surgery and ask to speak with a nurse
Covid Care to focus on eligibility for antiviral medicines
Eligibility for antiviral medicine to treat COVID-19 will become the key focus of primary, Hauora provider and community pharmacy care from 1st October. This will ensure the people who are most at risk of serious outcomes from the virus receive the support they need.
The continued and greater focus on antiviral therapies reflects the transition to managing COVID-19 in the same way as other acute respiratory conditions.
People who are not at high risk of serious illness from COVID-19 can still access related healthcare at their doctor, hauora provider or pharmacy, but will be asked to pay just like they do for other health services.